Multigenic control of tuberculosis resistance: analysis of a QTL on mouse chromosome 7 and its synergism with sst1.
Tuberculosis remains a significant global health problem: one-third of the human population is infected with Mycobacterium tuberculosis (MTB) and 10% of those are at lifetime risk of developing tuberculosis. In the majority of individuals infected, genetic determinants of susceptibility remain largely unknown due to complex multigenic control and the influence of genes--environment interactions. Genetic variation of host resistance to MTB in animal models reflects heterogeneity among humans. Stepwise dissection of these interactions will permit the deciphering of MTB's complex virulence strategy. Previously, we have characterized a mouse supersusceptibility locus (sst1) controlling antituberculosis immunity. In this study, eight host resistance quantitative trait loci (QTLs) were mapped that counter-balance the devastating effect of sst1, among which a QTL on chromosome 7 (Chr7) was most prominent. The Chr7 and sst1 loci independently control distinct resistance mechanisms to MTB, but their effects apparently converge on macrophages in remarkable synergy. Combining these resistance alleles on a C3HeB/FeJ-susceptible background reduced the lung pathology and improved survival after MTB challenge accounting for half of the difference between susceptible and resistant parental strains. These data reveal novel gene interactions controlling MTB resistance and will enable the identification of resistance gene(s) encoded within Chr7 locus.
Sissons
J
J
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Yan
B-S
BS
Pichugin
A V
AV
Kirby
A
A
Daly
M J
MJ
Kramnik
I
I
D000483:Alleles; D000818:Animals; D033481:Chromosomes, Mammalian; D003433:Crosses, Genetic; D004195:Disease Models, Animal; D004843:Epistasis, Genetic; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D008126:Lod Score; D008297:Male; D051379:Mice; D020297:Mice, Congenic; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D020161:Physical Chromosome Mapping; D040641:Quantitative Trait Loci; D018709:Statistics, Nonparametric; D014376:Tuberculosis / Q000235:genetics* / Q000276:immunology*
Annu Rev Genomics Hum Genet. 2001;2:373-400
11701655
Infect Immun. 2003 Jan;71(1):126-31
12496157
Immunology. 1999 Jan;96(1):16-21
10233673
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6610-5
12740444
Springer Semin Immunopathol. 1988;10(4):319-36
3146817
Am J Hum Genet. 1952 Dec;4(4):302-14
13016542
Annu Rev Genet. 2006;40:469-86
17094741
Annu Rev Genomics Hum Genet. 2007;8:163-92
17492906
J Intern Med. 2007 Feb;261(2):106-11
17241175
J Infect Dis. 1999 Jul;180(1):150-5
10353873
Novartis Found Symp. 1998;217:120-31; discussion 132-7
9949805
J Exp Med. 1965 Jun 1;121:1051-70
14319402
Annu Rev Immunol. 2004;22:599-623
15032590
Genes Immun. 2006 Apr;7(3):201-10
16452998
J Pathol. 2006 Jan;208(2):261-9
16362982
J Immunol. 2007 Nov 15;179(10):6919-32
17982083
Genes Immun. 2000 Dec;1(8):467-77
11197687
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8560-5
10890913
Novartis Found Symp. 2007;281:79-89; discussion 89-92, 208-9
17534067